Online Bill PayPatient Portal
 menu trigger  menu trigger

ULI-EAP-100

Study Information

Eligible Patient Population: Patients with advanced MAPK pathway—altered malignancies 

To learn whether you may be eligible for this program, please speak with your physician or contact our clinical research team.  

 

Contact HHO

All questions and feedback are welcome, anytime.


    About HHO

    Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.

    Menu

    Subscribe

    Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.

      © HHO 2022. All rights reserved. Designed by DRAW

      Online Bill PayPatient Portal